2019 (4) 7

Composite materials based on isocyanurate-containing polyurethane with a prolonged release of doxorubicin

 

S.A. Lukashevich, R.A. Rozhnova, G.A. Kozlova, L.Yu. Nechaeva

 

Institute of Macromolecular Chemistry NAS of Ukraine

48, Kharkivske shose, Kyiv, 02160, Ukraine; lsa2010new@ukr.net

 

Polym. J., 2019, 41, no. 4: 271-278.

 

Section: Medicine polymers.

 

Language: Ukrainian.

 

Abstract:

Based on polyoxypropylene glycol, TDI (2,4; 2,6-toluene diisocyanate), isocyanuraut HDT – 90 (2,4,6-triisocyanate (trishexamethylene) isocyanurate) and the lancinogluhydrazide adipic acid extender (ADH) for a different molar conjugate – dihydrazide of adipic acid for a different molar conjugate – dihydrazide of adipic acid (ADH), for a different molar conjugate – dihydrazide of adipic acid, for the same time, the adduct of the lancinoglu – dihydrazide of adipic acid ADH for a different molar conjugate – dihydrazide of adipic acid for a different molar ratio of adipic acid – ADH for a different molar ratio — adidic acid for the same molar – dihydride bond of adipic acid for the same time new polymeric materials with isocyanurate branching units. According to the studies, the dependence of tensile strength and elongation in branched polyurethanes on the ratio of TDI to TITGMI was established. IR spectroscopic studies found that doxorubicin being in low concentrations in the polymer does not affect changes in the spectra. Comparing the physicomechanical parameters of a polyurethane matrix without doxorubicin with synthesized composite materials, it was found that the introduction of isocyanurate heterocyclic fragments and doxorubicin to the polymer leads to an increase in tensile strength and a decrease in elongation. According to the results of the study of the yield dynamics of the drug, it was found that with an increase in the content of the isocyanurate component in the polymer matrix, the amount of doxorubicin released increases.

 

Keywords: polyurethanes (PU), doxorubicin (Dox), adipic acid dihydrazide (ADH), output dynamics, implants.

References

  1. Ferreira M. J., Duarte N., Gyemant N. Interaction between doxorubicin and the resistance modifier stilbene on multidrug resistant mouse lymphoma and human breast cancer cells. Anticancer Res. 2006. 26, no. 5A: 35–41.
  2. Zubareva A. A. Razrabotka sistem dostavki biologicheski aktivnyh veschestv na osnove nanochastic hitozana i ego proizvodnyh. Avtoreferat dissertacii na soiskanie uchenoy stepeni kandidata himicheskih nauk. Moskva, 2013.
  3. Averin P.S., Lopes de Gerenyu A. V., Balabushevich N. G. Polielektrolitnye mikro- i nanochasticy s doksorubicinom. Vestn. mosk. un-ta. Ser. 2. Himiya. 2016. 57, no. 2: 120–126.
  4. Sayfina L. F. Sintez i antimikobakterialnaya aktivnost izocianuratov, soderjaschih tiolny’e, sulfidnye, sulfinilnye, sulfonilnye gruppy v N-alkilnoy cepi : Dissertaciya kandidata himicheskih nauk : 02.00.03.
  5. Malanchuk V.A., Astapenko E.A., Galatenko N.A., Rojnova R.A. Rezultaty issledovaniya fiziko-mehanicheskih svoystv biodegradiruemogo polimera, ispolzuemogo v rekonstruktivno-vosstano-vitelnoy hirurgii kostey chelyustno-licevoy oblasti. Vi’snik problem biologii i medicini. 2013, 2, no. 100: 304–308.
  6. Gorbatenko V.I. Izocianaty. Metody sinteza i fiziko-himicheskie svoystva alkil-, aril, i geterilizocianatov. K.: Naukova dumka, 1987: 444.
  7. Rudenchik T. V., Rozhnova R. A., Galatenko N. A., Nechaeva L. Yu., Kiselova T. O. Rozrobka kompoziciynih materialiv na osnovi oligooksipropilenfumaratu, dimetakrilat trietilenglikolyu ta N-vinilpirolidonu, yaki mistyat’ imunomodulyator levamizol, i doslidjennya dinamiki yogo vivilnennya. Naukovi zapiski NaUKMA. 2015. 170: 53–58.
  8. Stashenko K. V., Rudenchik T. V., Rozhnova R. A., Kiselova T. O. Sintez ta doslidjennyakompoziciynih materialiv na osnovi poliuretansechovin z fragmentami kopolimeru polivinilbutiralyu, vinilacetatu ta vinilovim spirtom ta lizocimom. Zbirnik statey «Fundamentalni ta prikladni doslidjennya v suchasniy himii». V Mijnarodna zaochna naukovo-praktichna konferenciya molodih vchenih, 2018: 135–138.
  9. Gorbunova N.A., Galatenko N.A., Rozhnova R.A., Kuksin A.N. Novye nanostrukturirovannye bioaktivnye kompozicionnye materialy medicinskogo naznacheniya / International Scientific and Technical Conference. “Polimernye kompozity i tribologiya”, 22-25 06.2009. Belarus, Gomel, 2009: 62.
  10. Grekov, A. P. Organicheskaya himiya gidrazina / A. P. Grekov. Kiev: Tehnika, 1966: 235.
  11. Resiak I., Rokicki G. Modyfikowane poliuretany do zastosowan medycznych. Polimery. 2000, no. 9: 592–602. https://doi.org/10.14314/polimery.2000.592
  12. Elbl L., Vasova I., Navratil M., Tomaskova I., Jedlicka F., Chaloupka V., Mayer J., Vorlicek J. Late cardiotoxicity in patients with malignant lymphoma treated with doxorubicin chemotherapy. J Vnitr Lek. 2006. 52, no. 4: 328–38.
  13. Ipatova O.M., Zykova M.G., Torhovskaya T.I., Medvedeva N.V., Prozorovskiy V.N. Vozmojnosti ispolzovaniya fosfolipidnoy nanosistemy s glicirrizinovoy kislotoy (Fosfogliv) dlya optimizacii lekarstvennyh preparatov, na primere doksorubicina i budesonida. Biomedicinskaya himiya, 2009, 55, no. 2: 185–194.
  14. Grigor’ev G.P., Fedotova O.Ya. Laboratornyy praktikum po tehnologii plasticheskih mass. CHast 1: Uchebnoe posobie – M.: Vy’sshaya shkola, 1977: 248.
  15. Jaouen G. Bioorganometallics. Weinheim, Germany: Wiley-VCH, 2006: 444. https://doi.org/10.1002/3527607692
  16. Prech E., Byulmann F., Affolter K. Opredelenie stroeniya organicheskih soedineniy. M.: Mir; BINOM. Laboratoriya znaniy, 2006: 55.
  17. Lukashevich S. A., Rozhnova R. A., Galatenko N. A., Kozlova G. A. Rozrobka metodu sintezu poliuretaniv z izocianuratnimi vuzlami rozgalujennya. Doslidjennya ih strukturi ta vlastivostey. Visnik ONU. 2016, 21, no. 4(60): 48–56. https://doi.org/10.18524/2304-0947.2016.4(60).83667
  18. Kozlova T.B., Letunovskiy M.P., Jarkov B.B. Vliyanie himicheskoy sshivki na vodorodnye svyazi v uretanovy’h blok sopolimerah. Vysokomol. soed. 1983, 25, no. 9: 1929–1933.
  19. Beck R. A., Truss R.W. Effect of chemical structure on the wear behavior of polyurethane-urea elastomers. Wear 218(2):145-152·July 1998: 145152. https://doi.org/10.1016/S0043-1648(98)00219-1